Advertisement

Topics

ProSci Risk-Free Antibody Sets

20:00 EDT 10 Oct 2017 | Australian Life Scientist

Many antibodies work well in one application but not in others, despite detecting the same proteins. Because the target antigen may be denatured or inaccessible, depending on the technique or preparation, scientists must search and test multiple antibodies for one application and repeat the process again for a different application.

ProSci has recognised this issue and has released its Risk-Free Antibody Sets. Each set consists of several monoclonal antibodies (20 µg each) against a single target, allowing selection of the best clone for specific applications. Antibodies were developed using recombinant proteins expressed in mammalian cells to best recognise the native proteins.

The antibody sets are available for the following targets: PD-1, PD-L1, PD-L2, CD80, CTLA4, TIGIT and LIGHT. They have been rigorously tested for their designated applications: ELISA, flow, ICC, IF, IHC, pairs and WB.

Original Article: ProSci Risk-Free Antibody Sets

NEXT ARTICLE

More From BioPortfolio on "ProSci Risk-Free Antibody Sets"

Quick Search
Advertisement
 

Relevant Topics

Antibodies
An antibody is a protein produced by the body's immune system when it detects harmful substances, called antigens. Examples of antigens include microorganisms (such as bacteria, fungi, parasites, and viruses) and chemicals. Antibodies may be produc...

Biological Therapy
Biological therapy involves the use of living organisms, substances derived from living organisms, or laboratory-produced versions of such substances to treat disease. Some biological therapies for cancer use vaccines or bacteria to stimulate the body&rs...

Cloning
Cloning in biology is the process of producing similar populations of genetically identical individuals that occurs in nature when organisms such as bacteria, insects or plants reproduce asexually. Cloning in biotechnology refers to processes used to cre...